Table 1.
Association between Rab22a expression and clinical parameters in 101 patients with thyroid disease.
| Clinicopathological characteristics | Rab22a positive | Rab22a negative | Total | P |
|---|---|---|---|---|
| Age (Y) | ||||
| ≤55 | 42 | 11 | 53 | 0.280 |
| >55 | 12 | 6 | 18 | |
| Gender | ||||
| Male | 15 | 6 | 21 | 0.554 |
| Female | 39 | 11 | 50 | |
| Tumor size | ||||
| ≤2 cm | 35 | 13 | 48 | 0.553 |
| >2 cm | 19 | 4 | 23 | |
| Lymphatic metastasis | ||||
| Negative | 23 | 8 | 31 | 0.746 |
| Positive | 31 | 9 | 40 | |
| TNM stage | ||||
| I | 45 | 14 | 59 | 0.925 |
| II-IV | 9 | 3 | 12 | |
| BRAF | ||||
| Wild-type | 27 | 8 | 35 | 0.854 |
| V600E | 19 | 5 | 24 | |
| Histological type | ||||
| Papillary thyroid carcinoma | 24 | 7 | 31 | <0.001 |
| Follicular carcinoma | 24 | 9 | 33 | <0.001 |
| Thyroid medullary carcinoma | 6 | 1 | 7 | <0.001 |
| Nodular goiter | 0 | 30 | 30 |
P <0.05 (Fisher's test).